Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 10
2004 6
2005 4
2006 5
2007 11
2008 8
2009 12
2010 10
2011 15
2012 14
2013 15
2014 13
2015 17
2016 12
2017 4
2018 14
2019 11
2020 21
2021 19
2022 16
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
A phase 3 trial of bevacizumab in ovarian cancer.
Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators. Perren TJ, et al. N Engl J Med. 2011 Dec 29;365(26):2484-96. doi: 10.1056/NEJMoa1103799. N Engl J Med. 2011. PMID: 22204725 Free article. Clinical Trial.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Clinical Trial.
"Hot" acetogenesis.
Basen M, Müller V. Basen M, et al. Among authors: muller v. Extremophiles. 2017 Jan;21(1):15-26. doi: 10.1007/s00792-016-0873-3. Epub 2016 Sep 13. Extremophiles. 2017. PMID: 27623994 Review.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators. Oza AM, et al. Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016/S1470-2045(15)00086-8. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115797 Free PMC article. Clinical Trial.
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure.
Schierwagen R, Gu W, Brieger A, Brüne B, Ciesek S, Đikić I, Dimmeler S, Geisslinger G, Greten FR, Hermann E, Hildt E, Kempf VAJ, Klein S, Koch I, Mühl H, Müller V, Peiffer KH, Kestner RI, Piiper A, Rohde G, Scholich K, Schulz MH, Storf H, Toptan T, Vasa-Nicotera M, Vehreschild MJGT, Weigert A, Wild PJ, Zeuzem S, Engelmann C; ACLF-I Investigators,; Schaefer L, Welsch C, Trebicka J. Schierwagen R, et al. Among authors: muller v. Am J Physiol Cell Physiol. 2023 Jul 1;325(1):C129-C140. doi: 10.1152/ajpcell.00101.2023. Epub 2023 Jun 5. Am J Physiol Cell Physiol. 2023. PMID: 37273239 Free article. Review.
The Minimum Biological Energy Quantum.
Müller V, Hess V. Müller V, et al. Front Microbiol. 2017 Oct 25;8:2019. doi: 10.3389/fmicb.2017.02019. eCollection 2017. Front Microbiol. 2017. PMID: 29123504 Free PMC article. Review.
Overcoming Energetic Barriers in Acetogenic C1 Conversion.
Katsyv A, Müller V. Katsyv A, et al. Among authors: muller v. Front Bioeng Biotechnol. 2020 Dec 23;8:621166. doi: 10.3389/fbioe.2020.621166. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 33425882 Free PMC article. Review.
Energetics and Application of Heterotrophy in Acetogenic Bacteria.
Schuchmann K, Müller V. Schuchmann K, et al. Among authors: muller v. Appl Environ Microbiol. 2016 Jun 30;82(14):4056-4069. doi: 10.1128/AEM.00882-16. Print 2016 Jul 15. Appl Environ Microbiol. 2016. PMID: 27208103 Free PMC article. Review.
236 results